Welty FK - Search Results

1

Sex, Racial, and Ethnic Disparities in Acute Coronary Syndrome: Novel Risk Factors and Recommendations for Earlier Diagnosis to Improve Outcomes.

Khraishah H, Daher R, Garelnabi M, Karere G, Welty FK. Khraishah H, et al. Among authors: welty fk. Arterioscler Thromb Vasc Biol. 2023 Aug;43(8):1369-1383. doi: 10.1161/ATVBAHA.123.319370. Epub 2023 Jun 29. Arterioscler Thromb Vasc Biol. 2023. PMID: 37381984 Free PMC article. Review.

2

Cholesterol and apolipoprotein B metabolism in Tangier disease.

Schaefer EJ, Brousseau ME, Diffenderfer MR, Cohn JS, Welty FK, O'Connor J Jr, Dolnikowski GG, Wang J, Hegele RA, Jones PJ. Schaefer EJ, et al. Among authors: welty fk. Atherosclerosis. 2001 Nov;159(1):231-6. doi: 10.1016/s0021-9150(01)00688-8. Atherosclerosis. 2001. PMID: 11689226

3

Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.

Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK; Treating to New Targets Study Steering Committee and Investigators. Wenger NK, et al. Among authors: welty fk. Ann Intern Med. 2007 Jul 3;147(1):1-9. doi: 10.7326/0003-4819-147-1-200707030-00002. Ann Intern Med. 2007. PMID: 17606955 Free article. Clinical Trial.

4

Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma.

Sun Z, Welty FK, Dolnikowski GG, Lichtenstein AH, Schaefer EJ. Sun Z, et al. Among authors: welty fk. Am J Clin Nutr. 2001 Sep;74(3):308-14. doi: 10.1093/ajcn/74.3.308. Am J Clin Nutr. 2001. PMID: 11522553

5

The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.

Jenner JL, Seman LJ, Millar JS, Lamon-Fava S, Welty FK, Dolnikowski GG, Marcovina SM, Lichtenstein AH, Barrett PH, deLuca C, Schaefer EJ. Jenner JL, et al. Among authors: welty fk. Metabolism. 2005 Mar;54(3):361-9. doi: 10.1016/j.metabol.2004.10.001. Metabolism. 2005. PMID: 15736114

6

Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association.

Regensteiner JG, Golden S, Huebschmann AG, Barrett-Connor E, Chang AY, Chyun D, Fox CS, Kim C, Mehta N, Reckelhoff JF, Reusch JE, Rexrode KM, Sumner AE, Welty FK, Wenger NK, Anton B; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, Council on Functional Genomics and Translational Biology, and Council on Hypertension. Regensteiner JG, et al. Among authors: welty fk. Circulation. 2015 Dec 22;132(25):2424-47. doi: 10.1161/CIR.0000000000000343. Epub 2015 Dec 7. Circulation. 2015. PMID: 26644329 Review. No abstract available.

7

Lactoferrin concentration during involution of the bovine mammary gland.

Welty FK, Smith KL, Schanbacher FL. Welty FK, et al. J Dairy Sci. 1976 Feb;59(2):224-31. doi: 10.3168/jds.s0022-0302(76)84188-4. J Dairy Sci. 1976. PMID: 1249287

8

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.

Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154

9

Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial.

Raggi P, Callister TQ, Davidson M, Welty FK, Bachmann GA, Laskey R, Pittman D, Kafonek S, Scott R. Raggi P, et al. Among authors: welty fk. Am Heart J. 2001 May;141(5):722-6. doi: 10.1067/mhj.2001.114372. Am Heart J. 2001. PMID: 11320358 Clinical Trial.

10

Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).

Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Raggi P, et al. Among authors: welty fk. Circulation. 2005 Jul 26;112(4):563-71. doi: 10.1161/CIRCULATIONAHA.104.512681. Epub 2005 Jul 11. Circulation. 2005. PMID: 16009795 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters